Neonatal Porcine Germ Cells Dedifferentiate and Display Osteogenic and Pluripotency Properties

Abstract

Gonocytes are progenitors of spermatogonial stem cells in the neonatal testis. We have previously shown that upon culturing, neonatal porcine gonocytes and their colonies express germ cell and pluripotency markers. The objectives of present study were to investigate in vitro trans-differentiation potential of porcine gonocytes and their colonies into cells from three germinal layers, and to assess pluripotency of cultured gonocytes/colonies in vivo. For osteogenic and tri-lineage differentiation, cells were incubated in regular culture media for 14 and 28 days, respectively. Cells were cultured for an additional 14 days for osteogenic differentiation or 7 days for differentiation into derivates of the three germinal layers. Osteogenic differentiation of cells and colonies was verified by Alizarin Red S staining and tri-lineage differentiation was confirmed using immunofluorescence and gene expression analyses. Furthermore, upon implantation into recipient mice, the cultured cells/colonies developed teratomas expressing markers of all three germinal layers. Successful osteogenic differentiation from porcine germ cells has important implications for bone regeneration and matrix formation studies. Hence, gonocytes emerge as a promising source of adult pluripotent stem cells due to the ability to differentiate into all germinal layers without typical biosafety risks associated with viral vectors or ethical implications.

Optimal isolation, culture, and in vitro propagation of spermatogonial stem cells in Huaixiang chicken

“…SSCs have the unique dual ability to self‐renew and undergo differentiation to ultimately produce sperm. They have also been shown to have the potential to be transdifferentiated into multiple cell types in vitro (Fayaz et al., 2021). Hence, SSCs could be considered an alternative to embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) to avoid the potential ethical or safety issues surrounding stem cell research and cell‐mediated gene therapy.…”